These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 11950919)
1. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Klein WM; Hruban RH; Klein-Szanto AJ; Wilentz RE Mod Pathol; 2002 Apr; 15(4):441-7. PubMed ID: 11950919 [TBL] [Abstract][Full Text] [Related]
2. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
3. Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion. Hermanová M; Nenutil R; Kren L; Feit J; Pavlovský Z; Díte P Neoplasma; 2004; 51(5):400-4. PubMed ID: 15640947 [TBL] [Abstract][Full Text] [Related]
4. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719 [TBL] [Abstract][Full Text] [Related]
10. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215 [TBL] [Abstract][Full Text] [Related]
11. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
12. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
13. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. Osvaldt AB; Wendt LR; Bersch VP; Backes AN; de Cássia A Schumacher R; Edelweiss MI; Rohde L Surgery; 2006 Nov; 140(5):803-9. PubMed ID: 17084724 [TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1). Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415 [TBL] [Abstract][Full Text] [Related]
16. [Precursors to pancreatic cancer]. Søreide K; Immervoll H; Molven A Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881 [TBL] [Abstract][Full Text] [Related]
17. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336 [TBL] [Abstract][Full Text] [Related]
18. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420 [TBL] [Abstract][Full Text] [Related]